September 2016

Nearly 1,000 students across more than 20 health fields took part in the first ever Dalmazing Interprofessional Challenge last week.

Working with partners such as Halifax’s Agada Biosciences and the Vancouver-based Centre for Drug Research and Development, Dalhousie Medical School researchers are taking new orphan disease treatments from the lab and moving them to market.

Dalhousie Medical School researchers believe they’ve discovered a drug that will prevent babies born with a genetic blinding disease called Familial Exudative Vitreoretinopathy (FEVR) from losing their vision.

Dalhousie researchers Rudolf Uher, John Archibald and Jennifer Bain have been named to the Royal Society of Canada's College of New Scholars, Artists and Scientists.